Approval · Notice of Compliance 8972 · 2007
AVAMYS: Notice of Compliance 8972
Issued August 14, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8972
- Date
- August 14, 2007
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVAMYS | 02298589 | Marketed |
Medicinal ingredients
- FLUTICASONE FUROATE 27.5 MCG per ACT